Boost ROI with scalable, high-throughput 3D platforms that cut variability and per-sample costs, maximize limited cells, and localize production to offset tariffs.Dublin, Oct. (GLOBE NEWSWIRE) -- "3D ...
The growth and death of cancer cells in the lab are studied primarily in two-dimensional cell cultures. In a study published ...
A research team has developed a support-bath bioprinting method that enables fragile, mature human adipocytes to be ...
Roche researchers validate a human 3D immune-containing colorectal cancer assembloid platform that captures interferon-gamma ...
Developing chemotherapy drugs against breast cancer is costly, slow, and often inefficient, with more than 95% of screened drug candidates failing in patient trials. A new technique for 3D cell ...
CellFiber Co., Ltd., a Tokyo-based biotechnology company developing 3D cell culture and bioprocessing technology for ...
A new systems-level study in 3D lung adenocarcinoma models shows that nutrient availability drives tumour cells into two ...
Article reviewed by Julía Crispim da Fontoura, a PhD candidate at the Federal University of Health Sciences of Porto Alegre, Brazil who uses organoids to study drug resistance. Stay up to date on the ...
The drug discovery and characterization field has seen vast improvements in complexity, adaptation to human models, and accuracy as cell model options have become increasingly better suited to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results